MedTrace Logo

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome

NCT02483351 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-04-04

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).

Conditions

  • Subarachnoid Hemorrhage

Interventions

OTHER

Liberal Red Blood Cell Transfusion Strategy

RBC Transfusion strategy with hemoglobin trigger of 100g/L

OTHER

Restrictive Red Blood Cell Transfusion Strategy

Optional RBC Transfusion with hemoglobin trigger of \<=80g/L

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Shane English, MD MSc FRCPC · Ottawa Hospital Research Institute

  • Lauralyn McIntyre, MD MSc FRCPC · Ottawa Hospital Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02483351 on ClinicalTrials.gov